Unintended consequences of decreased PSA-based prostate cancer screening
Thomas E. Ahlering(University of California, Riverside), Jim C. Hu(Presbyterian Hospital), Kamaljot S. Kaler(University of California, Irvine), Linda My Huynh(University of California, Irvine), Stephen B. Williams(Cedars-Sinai Medical Center), Jihad Kaouk(Cleveland Clinic), Kathryn Osann, Isaac Yi Kim(Yale New Haven Hospital), Vipul Patel(University of Central Florida), Ronney Abaza(OhioHealth), John W. Davis(The University of Texas MD Anderson Cancer Center), David I. Lee(University of California, Irvine), Jean Joseph, James Porter(Swedish Medical Center)
Cited by 41
Related Papers
Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus
|Journal of the American College of Cardiology|1996|1k
Acute Hyperglycemia Attenuates Endothelium-Dependent Vasodilation in Humans In Vivo
|Circulation|1998|804
Epidemiology, Screening, and Prevention of Bladder Cancer
|European Urology Oncology|2022|361
NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016
|Journal of the National Comprehensive Cancer Network|2016|345
Robotic Versus Laparoscopic Partial Nephrectomy: A Systematic Review and Meta-Analysis
|European Urology|2012|290